# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-005226
Filing Date
2018-01-08
Accepted
2018-01-08 09:01:07
Documents
37
Period of Report
2018-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d522217d8k.htm | 8-K | 16225
2 | EX-99.1 | d522217dex991.htm | EX-99.1 | 25711
3 | GRAPHIC | g522217ex99_1s10g1.jpg | GRAPHIC | 263661
4 | GRAPHIC | g522217ex99_1s11g1.jpg | GRAPHIC | 282629
5 | GRAPHIC | g522217ex99_1s12g1.jpg | GRAPHIC | 319225
6 | GRAPHIC | g522217ex99_1s13g1.jpg | GRAPHIC | 212887
7 | GRAPHIC | g522217ex99_1s14g1.jpg | GRAPHIC | 320838
8 | GRAPHIC | g522217ex99_1s15g1.jpg | GRAPHIC | 300419
9 | GRAPHIC | g522217ex99_1s16g1.jpg | GRAPHIC | 312857
10 | GRAPHIC | g522217ex99_1s17g1.jpg | GRAPHIC | 252001
11 | GRAPHIC | g522217ex99_1s18g1.jpg | GRAPHIC | 321246
12 | GRAPHIC | g522217ex99_1s19g1.jpg | GRAPHIC | 194798
13 | GRAPHIC | g522217ex99_1s1g1.jpg | GRAPHIC | 380350
14 | GRAPHIC | g522217ex99_1s20g1.jpg | GRAPHIC | 379280
15 | GRAPHIC | g522217ex99_1s21g1.jpg | GRAPHIC | 292655
16 | GRAPHIC | g522217ex99_1s22g1.jpg | GRAPHIC | 381321
17 | GRAPHIC | g522217ex99_1s23g1.jpg | GRAPHIC | 247530
18 | GRAPHIC | g522217ex99_1s24g1.jpg | GRAPHIC | 324958
19 | GRAPHIC | g522217ex99_1s25g1.jpg | GRAPHIC | 251840
20 | GRAPHIC | g522217ex99_1s26g1.jpg | GRAPHIC | 204877
21 | GRAPHIC | g522217ex99_1s27g1.jpg | GRAPHIC | 346217
22 | GRAPHIC | g522217ex99_1s28g1.jpg | GRAPHIC | 243927
23 | GRAPHIC | g522217ex99_1s29g1.jpg | GRAPHIC | 295996
24 | GRAPHIC | g522217ex99_1s2g1.jpg | GRAPHIC | 609295
25 | GRAPHIC | g522217ex99_1s30g1.jpg | GRAPHIC | 542277
26 | GRAPHIC | g522217ex99_1s31g1.jpg | GRAPHIC | 239952
27 | GRAPHIC | g522217ex99_1s32g1.jpg | GRAPHIC | 127005
28 | GRAPHIC | g522217ex99_1s33g1.jpg | GRAPHIC | 518238
29 | GRAPHIC | g522217ex99_1s34g1.jpg | GRAPHIC | 369361
30 | GRAPHIC | g522217ex99_1s35g1.jpg | GRAPHIC | 316807
31 | GRAPHIC | g522217ex99_1s3g1.jpg | GRAPHIC | 174103
32 | GRAPHIC | g522217ex99_1s4g1.jpg | GRAPHIC | 269647
33 | GRAPHIC | g522217ex99_1s5g1.jpg | GRAPHIC | 238081
34 | GRAPHIC | g522217ex99_1s6g1.jpg | GRAPHIC | 211747
35 | GRAPHIC | g522217ex99_1s7g1.jpg | GRAPHIC | 281511
36 | GRAPHIC | g522217ex99_1s8g1.jpg | GRAPHIC | 210119
37 | GRAPHIC | g522217ex99_1s9g1.jpg | GRAPHIC | 130691
| Complete submission text file | 0001193125-18-005226.txt |  | 14327657

Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 18515038
SIC: 2836 Biological Products, (No Diagnostic Substances)